English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A biosensor for measuring NAD+ levels at the point of care

MPS-Authors
/persons/resource/persons212623

Yu,  Qiuliyang
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons243469

Pourmandi,  Narges
Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons212625

Xue,  Lin
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons243471

Gondrand,  Corentin
Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons225871

Fabritz,  Sebastian
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons203696

Johnsson,  Kai
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Yu, Q., Pourmandi, N., Xue, L., Gondrand, C., Fabritz, S., Bardy, D., et al. (2019). A biosensor for measuring NAD+ levels at the point of care. nature metabolism, 1219-1225. doi:10.1038/s42255-019-0151-7.


Cite as: https://hdl.handle.net/21.11116/0000-0005-6119-2
Abstract
The cellular level of nicotinamide adenine dinucleotide (NAD+), through its different functions, affects cellular metabolism and signalling1,2,3. A decrease in the NAD+ content has been associated with various pathologies and physiological aging4,5, while strategies to boost cellular NAD+ levels have been shown to be effective against age-related diseases in many animal models6. The link between decreased NAD+ levels and numerous pathologies and physiological aging has triggered the need for a simple quantification method for NAD+, ideally applicable at the point of care. Here, we introduce a bioluminescent biosensor for the rapid quantification of NAD+ levels in biological samples, which can be used either in laboratories or at the point of care. The biosensor is a semisynthetic, light-emitting sensor protein that changes the colour of emitted light from blue to red on binding of NAD+. This NAD+-dependent colour change enables the use of the biosensor in paper-based assays in which NAD+ is quantified by measuring the colour of the emitted light by using either a simple digital camera or a plate reader. We used the approach to quantify NAD+ levels in cell culture, tissue and blood samples, yielding results that agreed with those from standard testing methods. The same biosensor furthermore allows the quantification of NAD+-dependent enzymatic activities in blood samples, thus expanding its utility as a tool for point-of-care diagnostics.